Silence Therapeutics

RNS Number : 6423T
FTSE Russell
25 November 2021
 

 

 


 

 

Silence Therapeutics (UK): Constituent Deletion
Changes in FTSE UK Index Series

25 November 2021

Subject to the expected cancellation of trading on AIM for Silence Therapeutics (UK, constituent), please see details of affected indexes and effective dates below:

 

 

Index

Effective From
Start of Trading

FTSE AIM UK 50 Index

30 November 2021

FTSE AIM 100 Index

30 November 2021

FTSE AIM All-Share Index

30 November 2021

 

 

 

 

 

 

 

 

For further information please contact FTSE Russell Client Services at info@ftserussell.com or call:

Australia

+1800 653 680

Hong Kong

+852 2164 3333

Japan

+81 3 4563 6346

London

+44 (0) 20 7866 1810

New York

+1866 551 0617

 

 

Alternatively please visit our website at www.ftserussell.com

Terms of Use | Copyright © 2021 FTSE Russell

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
FTSDKPBDPBDDCDB

Companies

Serica Energy (SQZ)
UK 100
FTSE quotes by TradingView

Latest directors dealings

All directors dealings today